Association between osteoprotegerin gene polymorphisms and cardiovascular disease in type 2 diabetic patients
Open Access
- 17 May 2013
- journal article
- Published by FapUNIFESP (SciELO) in Genetics and Molecular Biology
- Vol. 36 (2), 177-182
- https://doi.org/10.1590/s1415-47572013005000024
Abstract
Osteoprotegerin (OPG) gene polymorphisms (T245G, T950C and G1181C) have been associated with osteoporosis and early predictors of cardiovascular disease. The aim of this study was to evaluate whether these polymorphisms contribute to cardiovascular disease (CVD) in type 2 diabetic patients. We performed a case-control study with 178 CVD subjects with diabetes and 312 diabetic patients without CVD to assess the impact of variants of the OPG gene on the risk of CVD. The OPG gene polymorphisms were analyzed by using the polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP). There was no significant association between the T245G and G1181C polymorphisms and CVD in the additive genetic model (OR = 0.96, 95% CI 0.64-1.45, p = 0.79; OR = 1.06, 95% CI 0.81-1.39, p = 0.65, respectively). However, the C allele of the T950C polymorphism was independently associated with a risk of CVD in type 2 diabetic patients in this genetic model (OR = 1.38, 95% CI 1.07-1.80, p = 0.01). This study provides evidence that the C allele of the T950C polymorphism is associated with increased risk of CVD in diabetic patients. However, well-designed prospective studies with a larger sample size are needed to validate these results.Keywords
This publication has 35 references indexed in Scilit:
- The Distinctive Nature of Atherosclerotic Vascular Disease in Diabetes: Pathophysiological and Morphological InsightsCurrent Diabetes Reports, 2012
- The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetesDiabetologia, 2009
- Proinflammatory cytokines and receptor activator of nuclear factor κB-ligand/osteoprotegerin associated with bone deterioration in patients with Crohnʼs diseaseEuropean Journal of Gastroenterology & Hepatology, 2009
- Evolutionary Genetics of Coronary Heart DiseaseCirculation, 2009
- Association between osteoprotegerin gene polymorphism and coronary artery disease in Japanese menAtherosclerosis, 2006
- Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarctionClinical Science, 2005
- Dysregulated Osteoprotegerin/RANK Ligand/RANK Axis in Clinical and Experimental Heart FailureCirculation, 2005
- Osteoprotegerin Gene Polymorphisms in Men with Coronary Artery DiseaseJournal of Clinical Endocrinology & Metabolism, 2004
- Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO ConsultationDiabetic Medicine, 1998
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997